Introduction to haemostasis from a pharmacodynamic perspective.

Area of Science:

• Biochemistry
• Hematology
• Pharmacology

Background:

• Haemostatic system characterization has advanced, but sub-systems (coagulation, fibrinolysis, blood cells, platelets, vessel wall) are often studied independently.
• Traditional clotting and lysis assays offer limited pharmacological information and do not capture the system's complexity.

Purpose of the Study:

• To advocate for integrated approaches in assessing the haemostatic system.
• To emphasize the need for pharmacodynamic tests that evaluate treatments within the context of the whole system.
• To address the limitations of current specific factor assays.

Main Methods:

• Review of current biochemical characterization methods for the haemostatic system.
• Analysis of the limitations of traditional and specific factor assays.
• Discussion on the necessity of integrated and global testing methodologies.

Main Results:

• Existing methods for characterizing the haemostatic system are often fragmented, studying sub-systems in isolation.
• Specific factor assays provide limited pharmacological insight and do not account for interindividual variability.
• There is a significant need for integrated or global methods to assess the haemostatic system's complexity and individual status.

Conclusions:

• Integrated testing is essential for a comprehensive understanding of the haemostatic system.
• Individually tailored treatments are required due to broad interindividual variability in haemostasis.
• Developing global methods will enable practitioners to better judge intervention effects and individual responses, balancing efficacy and safety.